In the present study, we found that methylation of the p16 proximal promoter nucleosome was only observed in GC samples making this location a possible candidate for further development of a tumor biomarker, and that nearly all of the p16 molecules with promoter methylation were found to be fully methylated in GC samples. The gene discussed is CDKN2A; the disease is neoplasm.